Minutes - Medication WG 2021-06-08

Attendees

• Anne Nerenhausen
• Annemieke Vergauwe
• Bruno Casneuf
• Jean-Michel Polfliet
• José Costa Teixeira
• Katrien Thorré
• Karlien Erauw
• Nick Hermans
• Pablo Christiaens
• Richard Francken
• Robin Bosman
• Thomas Van Langendonck
• Tom De Backer
• Tom Henkens

Excused/Not present

• Dieter Sauvillers
• Elhassan Baazizi
• Hanne Vuegen
• Jan Lenie
• Jean-Louis Maggetto
• Jens Penny
• Jeroen De Wilde
• Lars Vanreppelen
• Marc Buckens
• Nils Devos
• Richard Francken
• Will van Norel

Agenda

• review of SAMv1 to SAMv2 mapping
• review of the examples

Minutes

• Magistral
• FAGG has sent us through RIZIV a mapping SAMv1 to SAMv2, that was sent to all WG-members last week

• please collect feedback in your team and send it by email to Karlien

• feedback on the FHIR medication workshop that took place with a couple of WG-members last week

• “Stofnaam” aka “Substance” should be changed by VOS-cluster. Under a VOS-cluster we understand the following:

• Same substance(s)
• Same strength
• Comparable package size
• Form of administration
• Additional info:

• https://www.riziv.fgov.be/nl/themas/kost-terugbetaling/door-ziekenfonds/geneesmiddel-gezondheidsproduct/geneesmiddel-voorschrijven/Paginas/goedkoopste-geneesmiddelen.aspx
• https://www.riziv.fgov.be/nl/themas/kost-terugbetaling/door-ziekenfonds/geneesmiddel-gezondheidsproduct/geneesmiddel-voorschrijven/Paginas/voorschijven-stofnaam-regels-voorschrijver.aspx

• to check: Contramal 100 mg vs Contramal 100 mg retard
• comparable package sizes are not packaged in Belgium (was under discussion once)
• different VMP's are grouped in a cluster code, same administration code, not form of administration (disrriminiation of syrop vs pills is done through strength)

• During the workshop 12 scenario's have been defined:

• Prescribed branded medication is changed by another branded medication from the same VOS-cluster
• Prescribed medication is changed by another medication from a different VOS-cluster

• Different strength, different package size or different form of administration is dispensed
• Different substance(s) is dispensed

• Dispense medication before the prescription of the general practitioner

• e.g. stomach protector that is delivered to the patient

• Dispense of prescribed medication, and dispense of a product that can be done without a prescription
• Dispense of new brand medication that is given because the old is unavailable, so giving to continue the cure and not to replace it
• Refuse the dispense prescribed medication
• Dispense of medication that was prescribed, but not taken

• e.g. an antibiotic that is prescribed when doing international travel as a safeguard

• Dispense of medication that was prescribed, but not taken till the end

• e.g. an antibiotic that is prescribed but when using the patient had an allergic reaction
• might be connected to scenario 3, when the pharmacist gives an alternative

• The recording of anesthetic, contrast and similar medications in the medication scheme
• The recording of non-medication aka pharmaceutical products

• Food supplement
• Sunscreen
• ...

• The view and/or filters for

• a GP
• a nurse / caretaker
• a pharmacist
• a specialist
• a patient

• The patient is admitted to hospital and there the medication is changed to better help the patient.

• patient is admitted, hospital takes over the medication from the scheme
• patient is discharged, hospital reconciles the medication that was used with the medication scheme

• Do we have to extend the model to include individual prescriptions ?

• is the posology already sufficient as it is now in the model ?
• the regimen exists today and the model should foresee something similar
• for the pharmacist the time b/w the different intakes and with or without food is important
• José will be working on a use case for this

• Swiss approach of medication treatment plan

• doctor starts a medication treatment plan and everything afterwards is part of this plan
• Swiss documentation:

• Summary
• Detailed specifications v0.13

• In Belgium now we only have prescriptions, we don't have a starting point
• often a doctor starts with a prescription without it being part of a fixed plan (try-out)
• a medication can be part of multiple treatment plans
• this starting point (medication plan) does not seem to be mandatory, it can be optional
• Can we have a look at the Swiss documents and check what is useful for us (f.e. use cases)

Action items for next meeting

• José will work on a posology use case
• Review of Swiss documents

Next meeting June 22 at 11AM